Monica Else

3.6k total citations
42 papers, 2.0k citations indexed

About

Monica Else is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Monica Else has authored 42 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Genetics, 33 papers in Pathology and Forensic Medicine and 14 papers in Immunology. Recurrent topics in Monica Else's work include Chronic Lymphocytic Leukemia Research (40 papers), Lymphoma Diagnosis and Treatment (33 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). Monica Else is often cited by papers focused on Chronic Lymphocytic Leukemia Research (40 papers), Lymphoma Diagnosis and Treatment (33 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). Monica Else collaborates with scholars based in United Kingdom, United States and Italy. Monica Else's co-authors include Daniel Catovsky, Claire Dearden, Estella Matutes, Rachel Wade, Sue Richards, Zadie Davis, David Oscier, Nnenna Osuji, Peter Hillmen and Martin J.S. Dyer and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Monica Else

42 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monica Else United Kingdom 22 1.6k 1.2k 712 428 403 42 2.0k
Ilaria Del Giudice Italy 24 1.5k 0.9× 1.3k 1.0× 764 1.1× 331 0.8× 408 1.0× 82 1.9k
H. Döhner Germany 19 1.1k 0.7× 850 0.7× 507 0.7× 546 1.3× 441 1.1× 27 1.8k
Mariela Sivina United States 18 1.5k 0.9× 947 0.8× 778 1.1× 649 1.5× 367 0.9× 39 2.0k
Sílvia Marcé Spain 12 1.1k 0.7× 877 0.7× 599 0.8× 458 1.1× 306 0.8× 20 1.6k
Antonella Zucchetto Italy 23 1.2k 0.8× 862 0.7× 753 1.1× 492 1.1× 307 0.8× 79 1.8k
Marta Crespo Spain 19 1.5k 1.0× 1.3k 1.1× 925 1.3× 870 2.0× 619 1.5× 52 2.7k
William G. Wierda United States 18 1.8k 1.1× 1.4k 1.2× 948 1.3× 323 0.8× 358 0.9× 44 2.1k
Guillermo Dighiero Uruguay 11 1.3k 0.8× 970 0.8× 793 1.1× 303 0.7× 178 0.4× 15 1.7k
Pau Abrisqueta Spain 22 873 0.6× 1.0k 0.9× 421 0.6× 402 0.9× 636 1.6× 124 1.8k
Amber Gordon United States 8 1.2k 0.7× 792 0.7× 535 0.8× 432 1.0× 340 0.8× 14 1.5k

Countries citing papers authored by Monica Else

Since Specialization
Citations

This map shows the geographic impact of Monica Else's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Else with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Else more than expected).

Fields of papers citing papers by Monica Else

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Else. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Else. The network helps show where Monica Else may publish in the future.

Co-authorship network of co-authors of Monica Else

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Else. A scholar is included among the top collaborators of Monica Else based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Else. Monica Else is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Else, Monica, Stuart J. Blakemore, Jonathan C. Strefford, & Daniel Catovsky. (2021). The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trial. Leukemia. 35(9). 2563–2569. 7 indexed citations
2.
Bahlo, Jasmin, Nadine Kutsch, Michael Bergmann, et al.. (2015). THE INTERNATIONAL PROGNOSTIC INDEX FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL-IPI)-AN INTERNATIONAL META-ANALYSIS. Haematologica. 100. 313–314. 6 indexed citations
3.
Else, Monica, Claire Dearden, & Daniel Catovsky. (2015). Long-term follow-up after purine analogue therapy in hairy cell leukaemia. Best Practice & Research Clinical Haematology. 28(4). 217–229. 50 indexed citations
4.
González, David, Monica Else, Dörte Wren, et al.. (2012). CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes. Haematologica. 98(2). 274–278. 14 indexed citations
5.
Hockley, Sarah L., Monica Else, Alison Morilla, et al.. (2012). The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma. British Journal of Haematology. 158(3). 347–354. 44 indexed citations
6.
Dearden, Claire, Monica Else, & Daniel Catovsky. (2011). Long-term results for pentostatin and cladribine treatment of hairy cell leukemia. Leukemia & lymphoma. 52(sup2). 21–24. 48 indexed citations
7.
Else, Monica, Kim Cocks, Rachel Wade, et al.. (2011). Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial. Leukemia & lymphoma. 53(7). 1289–1298. 16 indexed citations
8.
Else, Monica, Claire Dearden, Estella Matutes, et al.. (2011). Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence. Leukemia & lymphoma. 52(sup2). 75–78. 39 indexed citations
9.
Jones, Gail, Nilima Parry‐Jones, Bridget S. Wilkins, Monica Else, & Daniel Catovsky. (2011). Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant*. British Journal of Haematology. 156(2). 186–195. 54 indexed citations
10.
Catovsky, Daniel, Monica Else, & Sue Richards. (2011). Chlorambucil—Still Not Bad: A Reappraisal. Clinical Lymphoma Myeloma & Leukemia. 11. S2–S6. 34 indexed citations
11.
Dearden, Claire, Sue Richards, Monica Else, Daniel Catovsky, & Peter Hillmen. (2010). A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trial. Cancer. 117(11). 2452–2460. 11 indexed citations
12.
Oscier, David, Rachel Wade, Zadie Davis, et al.. (2010). Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation. Haematologica. 95(10). 1705–1712. 81 indexed citations
13.
Else, Monica, Claire Dearden, Estella Matutes, et al.. (2009). Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. British Journal of Haematology. 145(6). 733–740. 175 indexed citations
14.
Morilla, Alison, David González de Castro, Ilaria Del Giudice, et al.. (2008). Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL. Leukemia & lymphoma. 49(11). 2108–2115. 32 indexed citations
15.
Else, Monica, Alastair G. Smith, Kim Cocks, et al.. (2008). Patients’ experience of chronic lymphocytic leukaemia: baseline health‐related quality of life results from the LRF CLL4 trial. British Journal of Haematology. 143(5). 690–697. 40 indexed citations
16.
17.
Else, Monica, Nnenna Osuji, Francesco Forconi, et al.. (2007). The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia. Cancer. 110(10). 2240–2247. 35 indexed citations
18.
Catovsky, Daniel, Estella Matutes, Martin J.S. Dyer, et al.. (2007). Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. The Lancet. 370(9583). 230–239. 482 indexed citations
19.
Dearden, Claire & Monica Else. (2006). Hairy cell leukemia. Current Oncology Reports. 8(5). 337–342. 9 indexed citations
20.
Else, Monica, Rosa Ruchlemer, Nnenna Osuji, et al.. (2005). Long remissions in hairy cell leukemia with purine analogs. Cancer. 104(11). 2442–2448. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilaria Del Giudice Breakdown of academic impact, for papers by H. Döhner Breakdown of academic impact, for papers by Mariela Sivina Breakdown of academic impact, for papers by Sílvia Marcé Breakdown of academic impact, for papers by Antonella Zucchetto Breakdown of academic impact, for papers by Marta Crespo Breakdown of academic impact, for papers by William G. Wierda Breakdown of academic impact, for papers by Guillermo Dighiero Breakdown of academic impact, for papers by Pau Abrisqueta Breakdown of academic impact, for papers by Amber Gordon
Rankless by CCL
2026